Sector consensus Roche Holding AG Swiss Exchange

Equities

Real-time Estimate Cboe Europe Other stock markets 09:49:05 22/04/2026 BST			5-day change	1st Jan Change
315.40 ^CHF	-0.57%		-0.28%	-4.20%

06:27am	Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths	RE
06:27am	Roche's fenebrutinib significantly reduced relapses in RMS	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
ELI LILLY AND COMPANY	1,210.55	+34.06%	29
JOHNSON & JOHNSON	252.42	+11.61%	24
ABBVIE INC.	249.43	+21.6%	30
ASTRAZENECA PLC	220.36	+12.05%	21
NOVARTIS AG	154.13	+3.6%	21
MERCK & CO., INC.	129.74	+15.26%	27
AMGEN INC.	352.73	+2.28%	30
NOVO NORDISK A/S	307.67	+24.51%	22
GILEAD SCIENCES, INC.	158.36	+18.81%	28
PFIZER INC.	28.97	+6.06%	27
BRISTOL-MYERS SQUIBB COMPANY	63.04	+6.15%	25
SANOFI	95.53	+17.91%	23
GSK PLC	20.48	-1.61%	20
VERTEX PHARMACEUTICALS INCORPORATED	548.45	+25.62%	29
CHUGAI PHARMACEUTICAL CO., LTD.	9,923.33	+14.14%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	6,036.87	+10%	15
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	80.33	+44.09%	17
BAYER AG	47.63	+19.17%	19
HALEON PLC	4.254	+20.75%	17
Average	1,046.54	+16.11%	23
Weighted average by Cap.	701.08	+17.65%	25